Search research articles
Contact Us
Filters
Showing results (431-440 of 538) with videos related to
Page
of 54
Sort By:
Pacing and Clinical Electrophysiology : PACE
|
June 24, 2020
Catheter ablation of atrial fibrillation in cardiac amyloidosis
Eric Black-Maier, Michael Rehorn, Rahul Loungani, et al.
American Heart Journal
|
September 21, 2015
Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)
Sameer Bansilal, Zachary Bloomgarden, Jonathan L Halperin, et al.
BMJ Open
|
March 2, 2022
Heart Watch Study: protocol for a pragmatic randomised controlled trial
Sanket S Dhruva, Nilay D Shah, Sreekanth Vemulapalli, et al.
American Heart Journal
|
March 18, 2020
Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation
Frederik Dalgaard, Rebecca North, Karen Pieper, et al.
JAMA Cardiology
|
November 29, 2018
Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II
Utibe R Essien, DaJuanicia N Holmes, Larry R Jackson, et al.
Heart (British Cardiac Society)
|
February 19, 2016
Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
Günter Breithardt, Helmut Baumgartner, Scott D Berkowitz, et al.
Heart Rhythm O2
|
October 20, 2021
Optimizing mechanically sensed atrial tracking in patients with atrioventricular-synchronous leadless pacemakers: A single-center experience
Kelly Arps, Jonathan P Piccini, Rebecca Yapejian, et al.
Journal of Cardiovascular Electrophysiology
|
January 14, 2022
Leadless pacemaker implantation after lead extraction for cardiac implanted electronic device infection
Li Bicong, John Carson Allen, Kelly Arps, et al.
Journal of the American Heart Association
|
April 24, 2014
Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial
Jonathan P Piccini, Anne S Hellkamp, Yuliya Lokhnygina, et al.
JACC. Cardiovascular Interventions
|
August 20, 2016
Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial
Matthew W Sherwood, Derek D Cyr, W Schuyler Jones, et al.
Page
of 54
Search research articles
Search
Showing results (431-440 of 538) with videos related to
Sort By:
Page
of 54
Pacing and Clinical Electrophysiology : PACE
|
June 24, 2020
Catheter ablation of atrial fibrillation in cardiac amyloidosis
Eric Black-Maier, Michael Rehorn, Rahul Loungani, et al.
American Heart Journal
|
September 21, 2015
Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)
Sameer Bansilal, Zachary Bloomgarden, Jonathan L Halperin, et al.
BMJ Open
|
March 2, 2022
Heart Watch Study: protocol for a pragmatic randomised controlled trial
Sanket S Dhruva, Nilay D Shah, Sreekanth Vemulapalli, et al.
American Heart Journal
|
March 18, 2020
Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation
Frederik Dalgaard, Rebecca North, Karen Pieper, et al.
JAMA Cardiology
|
November 29, 2018
Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II
Utibe R Essien, DaJuanicia N Holmes, Larry R Jackson, et al.
Heart (British Cardiac Society)
|
February 19, 2016
Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
Günter Breithardt, Helmut Baumgartner, Scott D Berkowitz, et al.
Heart Rhythm O2
|
October 20, 2021
Optimizing mechanically sensed atrial tracking in patients with atrioventricular-synchronous leadless pacemakers: A single-center experience
Kelly Arps, Jonathan P Piccini, Rebecca Yapejian, et al.
Journal of Cardiovascular Electrophysiology
|
January 14, 2022
Leadless pacemaker implantation after lead extraction for cardiac implanted electronic device infection
Li Bicong, John Carson Allen, Kelly Arps, et al.
Journal of the American Heart Association
|
April 24, 2014
Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial
Jonathan P Piccini, Anne S Hellkamp, Yuliya Lokhnygina, et al.
JACC. Cardiovascular Interventions
|
August 20, 2016
Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial
Matthew W Sherwood, Derek D Cyr, W Schuyler Jones, et al.
Page
of 54